SCHEMBL5772792

SCHEMBL5772792

CCOC(=O)C(C(=O)OCC)c1nc(Cl)ncc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
ALDH1A1 P00352 4/20 0.43
MAPT P10636 4/20 0.43
MAPK1 P28482 2/20 0.43
NPC1 O15118 1/20 0.43
TP53 P04637 1/20 0.43
XBP1 P17861 1/20 0.43
HTT P42858 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
HSD17B10 Q99714 1/20 0.43
TLR9 Q9NR96 1/20 0.43
TDP1 Q9NUW8 2/20 0.40
LMNA P02545 1/20 0.40
TSHR P16473 1/20 0.40
CYP1A2 P05177 3/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C19 P33261 2/20 0.38
RECQL P46063 1/20 0.38
CYP2C9 P11712 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21662990 0.77 KMT2A (0.39) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL24495521 0.76 ALDH1A1 (0.43) MEN1KMT2AALDH1A1MAPTTDP1
SCHEMBL21663006 0.76 STK17B (0.38) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL896209 0.75 MEN1 (0.56) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL21381504 0.74 MAPK1 (0.38) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL16709919 0.74 MAPT (0.67) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL30173602 0.74 MAPT (0.67) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL3968921 0.74 ALDH1A1 (0.39) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL9948150 0.73 MEN1 (0.54) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL13783520 0.73 MEN1 (0.54) MEN1KMT2AALDH1A1MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006066899-A1 NOVEL THROMBIN INHIBITORS SANTHERA PHARMACEUTICALS (SCHWEIZ) AG (CH) 2006-06-29 WO disclosed
EP-1674464-A1 Novel thrombin inhibitors Santhera Pharmaceuticals (Schweiz) GmbH (CH) 2006-06-28 EP disclosed
EP-1674464-A1 Novel thrombin inhibitors Santhera Pharmaceuticals (Schweiz) GmbH (CH) 2006-06-28 EP disclosed